Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 38Neoplasms 19Breast Neoplasms 9Head and Neck Neoplasms 5Colorectal Neoplasms 3Neoplasm Metastasis 2Carcinoma, Squamous Cell 2Adenocarcinoma 2Urologic Neoplasms 1Stomach Neoplasms 1Squamous Non-small Cell Lung Cancer 1Solid Tumors 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroectodermal Tumors 1NSCLC Harboring NRG1 Fusion 1Lung Neoplasms 1Glioma 1Glioblastoma 1Colonic Neoplasms 1Advanced Solid Tumors 1

Interventions

Temozolomide 94Radiotherapy 40Bevacizumab 40Lomustine 21Radiation 18Surgical Procedures, Operative 10Carboplatin 9pembrolizumab 8Nivolumab 8Carmustine 8Irinotecan 7IL13-PE38 6Granulocyte-Macrophage Colony-Stimulating Factor 6Flucytosine 6Cyclophosphamide 6ABT-414 6vocimagene amiretrorepvec 5depatuxizumab mafodotin 5Valacyclovir 5Drug Therapy 5veledimex 4sargramostim 4enzastaurin 4NVP-BKM120 4Gemcitabine 4Dianhydrogalactitol 4Chlorotoxin 4Aminolevulinic Acid 4verubulin 3selinexor 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Glioblastoma × Afatinib × Clear all
NCT00977431 2019-02-18

Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform

Boehringer Ingelheim

Phase 1 Completed
36 enrolled 16 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡